Lin, X., Wang, L., Xie, X., Qin, Y., Xie, Z., Ouyang, M., & Zhou, C. (2020). Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma. Front Mol Biosci.
Chicago Style CitationLin, Xinqing, Liqiang Wang, Xiaohong Xie, Yinyin Qin, Zhanhong Xie, Ming Ouyang, i Chengzhi Zhou. "Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma." Front Mol Biosci 2020.
Cita MLALin, Xinqing, et al. "Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma." Front Mol Biosci 2020.
Atenció: Aquestes cites poden no estar 100% correctes.